Someone else's clock has started running against them: the company is being paid to solve a problem that is already cost
The model's full reasoning — Q3 2018 call → NOWe need to answer YES or NO based on the transcript. The question asks if management describes that its counterparties are already losing something real and ongoing for as long as they do not have what the company provides, and that this accumulating loss is already visible in how those parties are behaving toward the company today. We need to find if there is a "running meter on the other side" and "the other side is already acting like the meter is running." Also need that this dynamic is generating business meaningful relative to company size and contribution still ahead. Let's analyze the transcript. Management discusses several products: ICP, IV-Cell, HemeScreen, and pathology services. For ICP: They have a partnership with Perkin Elmer. They said: "The co-marketing agreement recently announced is the first step in building a strong ongoing relationship with Perkin Elmer. Both companies are committed to this collaboration..." They talk about revenue potential. But is there a running meter? They don't describe Perkin Elmer losing money or opportunity while they don't have ICP. They just selected ICP. No mention of counterparty's accumulating loss. For IV-Cell: They say it enables labs to culture all 4 cell medias simultaneously, etc. They say "commercialization process proceeded in parallel to the ongoing academic study rather than waiting for the study to be completed." They say "interested parties -- partners that connected with us received samples of reagent and were able to test the IV-Cell technology in their own laboratory to see it works." That suggests parties are testing, but is there a running meter? No description of loss. For HemeScreen: They say "born from the frustrations of an existing test used in our CLIA lab, a test that suffered from high cost and long turnaround time, our R&D team sought to find a solution." They say "Since the launch of the test in our lab, only two weeks ago, we've already received numerous orders -- we've already run numerous orders received from physicians." That indicates orders coming in. But are those physicians losing something real and ongoing? They might be using an inferior test that has high cost and long turnaround time.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
SYM · Q3 2022 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...YES The transcript shows management describing customers' ongoing pain from labor shortages and broken supply chains that prevent them from handling demand, with customers actively clamoring for faster deployments and wanting the system as quickly as possible.
CRL · Q2 2022 → YESThe question is whether management describes that their counterparties are already losing something real and ongoing — money, output, access, standing, time, or an opportunity — for as long as they do...
GTES · Q4 2021 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...